tiprankstipranks
Trending News
More News >
Coherus Biosciences (CHRS)
NASDAQ:CHRS

Compare Coherus Biosciences (CHRS) vs. Competitors

Compare
1,638 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Coherus Biosciences
$1.60
$193.39M
-1.05
13.70%
3 Buy
0 Hold
0 Sell
Strong Buy
SELLAS Life Sciences Group
$4.11
$585.44M
-13.38
296.28%
2 Buy
0 Hold
0 Sell
Moderate Buy
Protalix
$2.06
$165.67M
29.64
-5.07%
1 Buy
0 Hold
0 Sell
Moderate Buy
Seres Therapeutics
$15.18
$145.47M
25.00
-2.69%
2 Buy
0 Hold
0 Sell
Moderate Buy
Innate Pharma
$1.75
$164.22M
-2.95
3.53%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CHRS
Coherus Biosciences
1.66
0.24
16.90%
SLS
SELLAS Life Sciences Group
3.84
2.86
291.84%
PLX
Protalix
2.06
-0.11
-5.07%
MCRB
Seres Therapeutics
15.18
0.48
3.27%
GNFT
IPHA
Innate Pharma
1.76
0.09
5.39%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts